Wishing our followers a joyful holiday season! As we reflect on the year, we are grateful for our dedicated team and their commitment to the work we do for individuals living with cancer. Here’s to a prosperous New Year ahead!
About us
The Menarini Group ("Menarini"), a leading Italian pharmaceutical and diagnostics company, and Stemline Therapeutics, Inc. ("Stemline"), a wholly-owned subsidiary of the Menarini Group focused on bringing transformational oncology treatments to people living with cancer. Inspired by the goal to improve outcomes for those with unmet medical needs, Menarini Stemline is driven to discover and develop innovative therapeutics for the treatment of cancer. Netiquette & Privacy Notice: https://bit.ly/48X6JSN
- Website
-
http://www.stemline.com
External link for Menarini Stemline
- Industry
- Biotechnology
- Company size
- 501-1,000 employees
- Headquarters
- New York, New York
- Type
- Public Company
Locations
-
Primary
Get directions
750 Lexington Avenue
11th Floor
New York, New York 10022, US
-
Get directions
Grafenaustrasse 3
Zug, 6300, CH
Employees at Menarini Stemline
Updates
-
Our team had an incredible experience connecting with the oncology community at #SABCS24 and sharing our latest updates for individuals living with breast cancer. We are looking forward to continuing our work to help improve outcomes for the patient community!
-
-
Menarini Group and MEDSIR present the Phase III study ADELA, a potential new therapeutic strategy for advanced breast cancer. Read today’s press release here: https://bit.ly/3OSZdA0
-
The Menarini Stemline team just wrapped up a productive few days in San Diego at #ASH24 with the global hematology community! We look forward to seeing the data presented in practice for the patient community.
-
-
The Menarini Stemline team is excited to connect with the breast cancer community at the San Antonio Breast Cancer Symposium this week! Be sure to visit our booth as we share our latest updates as we continue our work to bring transformational oncology treatments to individuals living with breast cancer. #SABCS24
-
We are excited to join the hematology community at the 2024 American Society of Hematology (ASH) Annual Meeting and Exposition this week! If you’re onsite, be sure to visit our booths to learn more about Menarini Stemline’s focus on bringing transformational oncology treatments to individuals living with hematologic cancers. #ASH24
-
As we gather to give thanks this holiday season, we express our gratitude to healthcare providers and patients everywhere. Your support and collaboration drive our work to find new options for individuals living with cancer. Wishing you all a joyful holiday! #Thanksgiving
-
-
Menarini Group presents new and expanded data at the 2024 San Antonio Breast Cancer Symposium in patients with ER+, HER2- advanced or metastatic breast cancer. Read today’s press release here: https://bit.ly/4fLfGSp
-
Every November we recognize those that play a vital role in the lives of patients – their caregivers. This #NationalCaregiversMonth, we thank you all for your dedication and selflessness. You inspire us all!
-